CD274 and glioblastoma: The predictive capacity of PD-L1 lost and showed an opposite trend in kidney clear cell carcinoma, small-cell lung cancer, mesothelioma, and glioblastoma (HRD = -0.02, -0.05, -0.35, and -0.38, respectively).